Megan S Lim, MD, PhD

faculty photo
Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania
Department: Pathology and Laboratory Medicine
Graduate Group Affiliations

Contact information
Department of Pathology and Laboratory Medicine
Stellar Chance Office Suite 609C
422 Curie Blvd.
Philadelphia, PA 19104
Office: 215-898-4719
Fax: 215-898-9969
BS (Cell and Microbiology)
University of Calgary, 1983.
MS (Biochemistry, Cell Regulation Group, Department of Medical Biochemistry, Faculty of Medicine)
University of Calgary, 1985.
MD (Medicine)
University of Calgary, 1988.
PhD (Molecular Oncology)
University of Calgary joint with National Cancer Institute, National Institute of Health, 1999.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Svoboda J, Bair SM, Landsburg DJ, Dwivedy Nasta S, Nagle SJ, Barta SK, Khan N, Filicko-O’Hara J, Gaballa S, Strelec L, Chong E, Mitnick S, Waite TS, King C, Ballard H, Youngman M, Gerson J, Plastaras JP, Maity A, Bogusz AM Hung SS, Nakamura H, Nejati R, Steidl C, Lim M, Ruella M, Schuster SJ. : Brentuximab vendotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomas. Heamatologica. Jacob M. Rowe (eds.). Ferrata Storti Foundation, 106(6): 1705-1713, June 2021.

Lowe EJ, Reilly AF, Lim MS, Gross TG, Saguilig L, Barkauskas DA, Wu R, Alexander S, Bollard CM.: Brentuximab Vedotin in Combination with Chemotherapy for Pediatric Patients with ALK+ALCL: Results of COG Trial ANHL12P1. Blood. Nancy Berliner, MD (eds.). American Society of Hematology, March 2021.

WHO Classification of Tumours Editorial Board: E. Campo, N. L. Harris, E. S. Jaffe, S. A. Pileri, H. Stein, J. Thiele, D. Arber, R. Hasserjian, M. Le: The WHO Classification of Tumours, 5th Edition. International Agency for Research on Cancer. E. Campo, N. L. Harris, E. S. Jaffe, S. A. Pileri, H. Stein, J. Thiele, D. Arber, R. Hasserjian, M. Le (eds.). International Agency for Research on Cancer, 2021.

Lim MS: Multicentric Castleman disease [maybe move under HHV8+ DLBCL; Anaplastic large cell lymphoma, ALK positive; Anaplastic large cell lymphoma, ALK negative. WHO Classification of Tumours, 5th edition-Haematolymphoid Tumours. Ian A. Cree (eds.). International Agency for Research on Cancer, 2021.

Pierson SK, Khor JS, Ziglar J, Liu A, Floess K, NaPier E, Gorzewski AM, Tamakloe MA, Powers V, Akhter F, Haljasmaa E, Jayanthan R, Rubenstein A, Repasky M, Elenitoba-Johnson KSJ, Ruth J, Jacobs B, Streetly M, Angenendt L, Patier JL, Ferrero S, Zinzani PL, Terriou L, Casper C, Jaffe E, Hoffman C, Oksenhendler E, Fosså A, Srkalovic G, Chadburn A, Uldrick TS, Lim M, van Rhee F, Fajgenbaum DC: ACCELERATE: A patient-powered natural history study design enabling clinical and therapeutic discoveries in a rare disorder. Cell Rep Med. Elsevier, 1(99), December 2020.

van Rhee F, Oksenhendler E, Srkalovic G, Voorhees P, Lim M, Dispenzieri A, Ide M, Parente S, Schey S, Streetly M, Wong R, Wu D, Maillard I, Brandstadter J, Munshi N, Bowne W, Elenitoba-Johnson KSJ, Fossä A, Lechowicz MJ, Chandrakasan S, Pierson SK, Greenway A, Nasta S, Yoshizaki K, Kurzrock R, Uldrick TS, Casper C, Chadburn A, Fajgenbaum DC: International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease. Blood Adv. Robert S. Negrin (eds.). American Society of Hematology, 4(23): 6039-50, December 2020.

Chunn LM, Nefcy DC, Ritter RW, Tarpey RP, Chuahan G, Lim MS, Elenitoba-Johnson KSJ, Schwartz SA and Kiel MJ.: Mastermind: A comprehensive genomic association search engine for empirical evidence curation and genetic variant interpretation. Front Genet. Emmanouil Dermitzakis, Field Chief Editors (eds.). Frontiers Media SA, 11, November 2020.

Fajgenbaum DC, Wu D, Goodman A, Wong R, Chadburn A, Nasta S, Srkalovic G, Mukherjee S, Leitch H, Jayanthan R, Ferrero S, Sato Y, Schey S, Dispenzieri A, Oksenhendler E, Zinzani PL, Lechowicz MJ, Hoffman C, Pemmaraju N, Bagg A, Fossa A, Lim MS, van Rhee F.: Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease. Am J Hematol. Wiley Periodicals, September 2020.

Hayashi RJ, Winter SS, Dunsmore KP, Devidas M, Chen Z, Wood BL, Hermiston M, Teachey DT, Perkins SL, Miles RR, Raetz EA, Loh ML, Winick NJ, Carroll WL, Hunger SP, Lim MS, Gross TG, Bollard CM: Successful Disease Control Without Cranial Radiation in Newly Diagnosed T Lymphoblastic Lymphoma (T-LL): Results from Children’s Oncology Group AALL0434. J Clin Oncol. Jonathan W. Friedberg, MD, MMSc (eds.). ASCO Publications, June 2020 Notes: Published online ahead of print.

Koh J, Jang I, Choi S, Kim S, Jang I, Ahn HK, Lee C, PaiK JH, Kim CW, Lim MS, Kim K*, Jeon YK*: Discovery of novel recurrent mutations and clinically meaningful subgroups in nodal marginal zone lymphoma. Cancers. MDPI, 12(6): 1669, June 2020.

back to top
Last updated: 08/03/2021
The Trustees of the University of Pennsylvania